Valeant Pharmaceuticals CEO J. Michael Pearson discusses an acquisition on CNBC (Screenshot from video)
23 Oct 2015

Pharma CEO Who Said He Only Cares About Shareholders Loses Them Money

Valeant CEO J. Michael Pearson let it be known that his company’s shareholders, not patients needing the company’s drugs, were his only real concern.